Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Diabetic miocardiopathy].

Ignacio Gil-Ortega1, Juan Carlos Kaski

  • 1Coronary Artery Disease Research Unit. Department of Cardiological Sciences. St. George's Hospital Medical School. Londres. Reino Unido. jkaski@sgul.ac.uk

Medicina Clinica
|December 6, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardiovascular prescriber attitudes to pharmacogenomics: a survey by the ESC working group on cardiovascular pharmacotherapy.

The pharmacogenomics journal·2026
Same author

Cardiovascular pharmacotherapy in 2025.

European heart journal. Cardiovascular pharmacotherapy·2026
Same author

Great debate: preventive percutaneous coronary intervention added to optimal medical treatment should be the default treatment for non-flow-limiting vulnerable plaques.

European heart journal·2026
Same author

Exercise treadmill testing for efficacy evaluation in randomized, controlled trials.

American heart journal·2026
Same author

Optimizing cardiovascular pharmacotherapy in older adults with frailty.

Nature reviews. Cardiology·2026
Same author

Adherence to guideline-directed medical treatments in heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Working Group on Cardiovascular Pharmacotherapy.

European journal of heart failure·2025
Same journal

Effectiveness of cardiac Holter monitoring for more than four weeks for the detection of occult atrial fibrillation in embolic stroke of undetermined source.

Medicina clinica·2026
Same journal

Artificial intelligence in surgical training and education: a narrative review.

Medicina clinica·2026
Same journal

Treatment of phantom limb syndrome with ketamine.

Medicina clinica·2026
Same journal

Comment on "Ticagrelor versus clopidogrel in patients with chronic coronary syndrome undergoing percutaneous coronary intervention: A propensity score-matched analysis".

Medicina clinica·2026
Same journal

Limitations in the interpretation of thyroid function tests.

Medicina clinica·2026
Same journal

Cerebrotendinous xanthomatosis without neurological manifestations: An atypical form with normal cholestanol levels.

Medicina clinica·2026
See all related articles

Diabetic cardiomyopathy, a heart condition in diabetes patients, is common and linked to poor outcomes. Biomarkers offer a promising diagnostic approach for early detection in asymptomatic individuals.

Area of Science:

  • Cardiology
  • Endocrinology
  • Biomarker Research

Context:

  • Diabetes mellitus prevalence is rising globally, driven by obesity and inactivity.
  • Cardiovascular diseases cause 80% of deaths in diabetic patients.
  • Diabetic cardiomyopathy is an underrecognized complication unrelated to traditional heart disease risk factors.

Purpose:

  • To review the role of cardiac biomarkers in diagnosing diabetic cardiomyopathy.
  • To propose a diagnostic algorithm for identifying this condition in asymptomatic diabetic patients.

Summary:

  • Diabetic cardiomyopathy affects a significant portion of diabetes patients, leading to poor prognosis.
  • Echocardiography screening is challenging in asymptomatic individuals.
  • Biomarkers are being investigated as a more feasible diagnostic tool.

Related Experiment Videos

Impact:

  • Early diagnosis of diabetic cardiomyopathy can lead to timely intervention.
  • A biomarker-based algorithm may improve patient outcomes and reduce cardiac mortality.
  • This research addresses a critical unmet need in diabetes management.